Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

26th Nov 2020 07:00

RNS Number : 5413G
Synectics PLC
26 November 2020
 

Synectics plc

("Synectics" or the "Company")

 

PDMR dealings

 

26 November 2020

 

Synectics (AIM: SNX), a leader in the design, integration and support of advanced security and surveillance systems, was notified on 25 November 2020 that on the same day David Aindow, a PDMR of the Company, purchased 2,000 ordinary shares of 20 pence each in the Company ("Ordinary Shares") at a price of 101 pence per share.

 

Following this purchase, the beneficial holding of Mr. Aindow is 2,000 Ordinary Shares, representing approximately 0.01 per cent. of the issued share capital of the Company.

 

 

-ends-

 

About Synectics plc

 

Synectics (AIM: SNX) is a leader in the design, integration and support of advanced security and surveillance systems that enable clients around the world to protect their people, communities, and assets.

 

Founded over 30 years ago, Synectics has deep industry experience across gaming, energy, urban transport, public space and critical infrastructure projects. The group's expert engineering teams work in partnership with customers to create integrated product and technology platforms, proven in the most complex and demanding operating environments.

 

Find out more at www.synecticsplc.com.

 

 

 

For further information, please contact:

 

Synectics plc

Claire Stewart, Company Secretary

Tel: +44(0) 114 280 2828

 

Shore CapitalTom Griffiths / David Coaten / Henry WillcocksTel: +44 (0) 20 7408 4050

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAPFSAEXEFFA

Related Shares:

Synectics
FTSE 100 Latest
Value8,634.80
Change0.00